155 related articles for article (PubMed ID: 37387737)
21. Retracted: An Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9823238. PubMed ID: 37593686
[TBL] [Abstract][Full Text] [Related]
22. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
[TBL] [Abstract][Full Text] [Related]
23. Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9847941. PubMed ID: 37811260
[TBL] [Abstract][Full Text] [Related]
24. Retracted: Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway.
International BR
Biomed Res Int; 2024; 2024():9838254. PubMed ID: 38550170
[TBL] [Abstract][Full Text] [Related]
25. Retracted: The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9858395. PubMed ID: 38550122
[TBL] [Abstract][Full Text] [Related]
26. Retracted: MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
International BR
Biomed Res Int; 2024; 2024():9840106. PubMed ID: 38230029
[TBL] [Abstract][Full Text] [Related]
27. Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9820871. PubMed ID: 38094444
[TBL] [Abstract][Full Text] [Related]
28. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
Liu B; Cao G; Dong Z; Guo T
Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
[TBL] [Abstract][Full Text] [Related]
29. Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation.
Khaddour K; Fields RC; Ansstas M; Rosman IS; Ansstas G
Hered Cancer Clin Pract; 2020 Nov; 18(1):23. PubMed ID: 33292409
[TBL] [Abstract][Full Text] [Related]
30. Retracted: BID-Net: An Automated System for Bone Invasion Detection Occurring at Stage T4 in Oral Squamous Carcinoma Using Deep Learning.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9754061. PubMed ID: 38074376
[TBL] [Abstract][Full Text] [Related]
31. The CUE1 domain of the SNF2-like chromatin remodeler SMARCAD1 mediates its association with KRAB-associated protein 1 (KAP1) and KAP1 target genes.
Ding D; Bergmaier P; Sachs P; Klangwart M; Rückert T; Bartels N; Demmers J; Dekker M; Poot RA; Mermoud JE
J Biol Chem; 2018 Feb; 293(8):2711-2724. PubMed ID: 29284678
[TBL] [Abstract][Full Text] [Related]
32. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
33. Retracted: Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer.
International EM
Emerg Med Int; 2024; 2024():9803436. PubMed ID: 38298957
[TBL] [Abstract][Full Text] [Related]
34. Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2022; 2022():9807439. PubMed ID: 36475012
[TBL] [Abstract][Full Text] [Related]
35. microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction].
Cancer Manag Res; 2021; 13():7249-7250. PubMed ID: 34566433
[TBL] [Abstract][Full Text] [Related]
36. Retracted: miR-206 Inhibits Laryngeal Carcinoma Cell Multiplication, Migration, and Invasion.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9783934. PubMed ID: 37388134
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.
Li S; Luo C; Zhou J; Zhang Y
Exp Ther Med; 2021 Nov; 22(5):1257. PubMed ID: 34603525
[TBL] [Abstract][Full Text] [Related]
38. [Retracted] miR‑365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl‑2.
Li M; Yang Y; Kuang Y; Gan X; Zeng W; Liu Y; Guan H
Exp Ther Med; 2023 Mar; 25(3):102. PubMed ID: 36761039
[TBL] [Abstract][Full Text] [Related]
39. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
[TBL] [Abstract][Full Text] [Related]
40. Retraction Notice to: Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma.
Feng C; Zhang HL; Zeng A; Bai M; Wang XJ
Mol Ther Nucleic Acids; 2022 Jun; 28():638. PubMed ID: 35615003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
